Applicant, as named in the Orange Book

Idorsia

Next listed expiry: Quviviq on 2 Dec 2034. 2 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Quviviq · 2 strengths daridorexant hydrochloride	daridorexant hydrochloride	214985	2 Dec 2034	patent
Tryvio aprocitentan	aprocitentan	217686	26 Jul 2038	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.